SL
Smith L. Mary
Directrice du Développement
OtherF
Insider track record
ExecutiveNot enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the full record of transactions filed by Smith L. Mary, Directrice du Développement. Director active across 2 companies, notably SpringWorks Therapeutics, Inc.. Aggregated, 16 reports have been published. History available since 13 July 2021. The latest transaction was filed on 4 January 2024 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations16 total
21,156 shares0Common StockSEC:0001104659-24-002380:0
5,720 sharesCommon StockSEC:0001104659-23-078084:0
1,068 shares@ US$26.416.1% of flowCommon StockSEC:0001104659-23-002695:0
22,663 sharesCommon StockSEC:0001104659-23-002318:0
1,551 shares@ US$28.479.8% of flowCommon StockSEC:0001104659-22-081242:0
6,092 shares0Common StockSEC:0001104659-22-077448:0
1,181 shares@ US$56.0615.8% of flowCommon StockSEC:0001104659-22-004463:0
1,181 shares@ US$56.0613.3% of flowCommon StockSEC:0001104659-22-004463
1,772 shares@ US$56.0623.7% of flowCommon StockSEC:0001104659-22-003144:0
1,772 shares@ US$56.0619.9% of flowCommon StockSEC:0001104659-22-003144
22,205 sharesCommon StockSEC:0001104659-22-002747
22,205 sharesCommon StockSEC:0001104659-22-002747:0
10,000 shares@ US$2.305.3% of flowCommon StockSEC:0001104659-21-125932:0
10,000 shares@ US$2.304.5% of flowCommon StockSEC:0001104659-21-125932
10,000 shares@ US$2.304.4% of flowCommon StockSEC:0001104659-21-092123
10,000 shares@ US$2.305.3% of flowCommon StockSEC:0001104659-21-092123:0
About Smith L. Mary
Mary L. Smith serves as the Chief Development Officer at SpringWorks Therapeutics, Inc. She oversees the company's strategic development initiatives, focusing on innovation and growth. Smith brings expertise in business development and project management, contributing to guiding the company's direction. Her commitment to operational excellence supports SpringWorks' mission.